Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zimmer buys Orthosoft

This article was originally published in The Gray Sheet

Executive Summary

Zimmer will integrate Orthosoft's Navitrack orthopedic surgery navigation software with its own Computer Assisted Solutions image-guided orthopedic surgery instrument offerings under a $47.5 million cash buy-out of the company, announced Aug. 23. Orthopedic implant maker Zimmer will pay $1.05 per share to acquire the 87.6% of Orthosoft shares it does not already own. The deal represents a 69% premium over Montreal, Canada-based Orthosoft's stock closing price on Aug. 23. Orthosoft's Navitrack software tools are used for total knee and hip replacements, running on the firm's Sesamoid portable integrated computer, camera and display system. The Navitrack FluoroSpine system also helps surgeons to precisely position pedicle screws during fluoroscopy-guided spine surgery. OrthoSoft generated 2006 revenue of about $12.1 million...

You may also be interested in...



California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.

Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer

Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025.  It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.

Xaira Launches With $1bn-Plus And End-To-End AI Strategy

ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025192

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel